Wang Huiwen, Zhang Li, Cao Liu, Zeng Ximin, Gillespie Barbara, Lin Jun
Department of Animal Science, The University of Tennessee, Knoxville, TN, 37996, USA.
Department of Poultry Science, Mississippi State University, Mississippi State, MS, 39762, USA.
Vet Microbiol. 2022 Apr;267:109379. doi: 10.1016/j.vetmic.2022.109379. Epub 2022 Feb 22.
Escherichia albertii is an emerging foodborne enteropathogen with increasing outbreaks worldwide, particularly in Japan recently. However, major features of this zoonotic pathogen, such as prevalence, virulence, and antibiotic resistance (AR), still remain under characterized. In a recent pilot study, we reported isolation of E. albertii from a chicken farm in Tennessee, suggesting chicken is an important reservoir for E. albertii. In this large-scale study, we examined prevalence of E. albertii in 9 farms in Mississippi and Alabama. Of a total of 270 cloacal swabs (30 per farm), 43 were PCR positive and 12 E. albertii strains were isolated with different isolation rates in individual farms ranging from 0 to 23.3 %. Both PFGE and whole genome analysis showed the E. albertii from different farms were phylogenetically distant, but those from the same farm displayed clonal relationships. Consistently, the antibiogram, AR gene profiles, and plasmid replicon types were similar across the strains in the same farm. Notably, 9 of the 12 E. albertii strains displayed multidrug resistance; one strain was even resistant to imipenem, a clinically important carbapenem antibiotic. In addition, comparative genomics analysis showed that two chicken E. albertii clusters displayed very close evolutionary relationships and similar virulence gene profiles to human E. albertii strains. In vitro growth assay demonstrated that the anti-enterobactin antibodies could dramatically inhibit the growth of two representative chicken E. albertii, supporting the feasibility of the novel enterobactin-based immune intervention for controlling this emerging pathogen. Taken together, the findings from this study further indicated chickens as an important reservoir for E. albertii in the U.S., highlighting the need to prevent and control E. albertii in poultry production.
艾氏埃希菌是一种新出现的食源性肠道病原体,在全球范围内暴发疫情呈上升趋势,尤其是最近在日本。然而,这种人畜共患病原体的主要特征,如流行率、毒力和抗生素耐药性(AR),仍未得到充分表征。在最近的一项初步研究中,我们报告了从田纳西州的一个养鸡场分离出艾氏埃希菌,表明鸡是艾氏埃希菌的重要宿主。在这项大规模研究中,我们检测了密西西比州和阿拉巴马州9个农场中艾氏埃希菌的流行情况。在总共270份泄殖腔拭子(每个农场30份)中,43份PCR呈阳性,分离出12株艾氏埃希菌,各农场的分离率不同,范围为0%至23.3%。PFGE和全基因组分析均显示,来自不同农场的艾氏埃希菌在系统发育上距离较远,但来自同一农场的菌株呈现克隆关系。同样,同一农场的菌株在抗菌谱、AR基因谱和质粒复制子类型方面相似。值得注意的是,12株艾氏埃希菌中有9株表现出多重耐药性;一株甚至对临床上重要的碳青霉烯类抗生素亚胺培南耐药。此外,比较基因组学分析表明,两个鸡源艾氏埃希菌群与人类艾氏埃希菌菌株显示出非常密切的进化关系和相似的毒力基因谱。体外生长试验表明,抗肠杆菌素抗体可显著抑制两株代表性鸡源艾氏埃希菌的生长,支持了基于新型肠杆菌素的免疫干预措施控制这种新出现病原体的可行性。综上所述,本研究结果进一步表明鸡是美国艾氏埃希菌的重要宿主,凸显了在家禽生产中预防和控制艾氏埃希菌的必要性。